Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
20+ Year Treas Bond Ishares ETF
(NQ:
TLT
)
138.91
USD
+0.27 (+0.19%)
Official Closing Price
Updated: 7:59 PM EST, Mar 5, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about 20+ Year Treas Bond Ishares ETF
< Previous
1
2
Next >
Theralase Announces Completion of Public Offering of Units
November 10, 2016
From
Marketwired
Theralase Announces Proposed Public Offering of Units
November 07, 2016
From
Marketwired
Theralase Provides Update on 2016 Strategic Initiatives
March 18, 2016
Tags
Company Update
Business & Professional Services
From
ACCESSWIRE
BlackRock’s iShares to Ring The Nasdaq Stock Market Closing Bell
February 26, 2016
From
GlobeNewswire News Releases
The Nasdaq Stock Market® Kicks Off the New Year With Strong ETP Momentum
February 08, 2016
BlackRock, Van Eck, and Legg Mason Among Leading ETF Issuers to Select Nasdaq as Primary Venue for Transitioned and New Listings in January
From
GlobeNewswire News Releases
BlackRock Announces Changes to Four iShares Treasury ETFs
January 28, 2016
Effective on or after March 31, 2016, BlackRock, Inc. will change the underlying indices for the following four iShares Treasury exchange traded funds (ETFs) from Barclays to ICE U.S. Treasury Bond...
From
Business Wire News Releases
Theralase Debuts Next Generation Therapeutic Laser in US
January 13, 2016
Tags
Business & Professional Services
Conferences
From
ACCESSWIRE
Theralase to Present at Noble Investor Conference
January 12, 2016
Tags
Business & Professional Services
Conferences
From
ACCESSWIRE
Theralase to Present at AlphaNorth Capital Conference
January 11, 2016
Tags
Business & Professional Services
Conferences
From
ACCESSWIRE
BlackRock Announces Primary Listing Venue Changes for 11 iShares ETFs
January 05, 2016
BlackRock, Inc. (NYSE:BLK) plans to change the primary listing venue for 11 iShares ETFs. The following funds are scheduled to move on or about February 2nd, 2016:
From
Business Wire News Releases
University Health Network Review Ethics Board Approves Clinical Study for Anti-Cancer Drug
December 28, 2015
Tags
Company Update
Business & Professional Services
From
ACCESSWIRE
Health Canada Approves Clinical Trial Application for Anti-Cancer Drug
December 16, 2015
Tags
Company Update
Business & Professional Services
Product Announcements
From
ACCESSWIRE
Theralase Launches Next Generation Therapeutic Laser in Canada
December 14, 2015
Tags
Product Announcements
Business & Professional Services
From
ACCESSWIRE
Health Canada Approves Next Generation TLC-2000 Therapeutic Laser
December 13, 2015
Tags
Product Announcements
Business & Professional Services
From
ACCESSWIRE
Theralase Releases 3Q 2015 Financials
November 26, 2015
Tags
Earnings
Business & Professional Services
From
ACCESSWIRE
Theralase Launches Next Generation Therapeutic Laser in USA
November 25, 2015
Tags
Business & Professional Services
Product Announcements
From
ACCESSWIRE
FDA Grants Approval for Next Generation Therapeutic Laser
November 24, 2015
Tags
Business & Professional Services
Company Update
From
ACCESSWIRE
Theralase Appoints Director of Clinical Education / Training and Clinic Director
November 23, 2015
Tags
Company Update
Business & Professional Services
From
ACCESSWIRE
Theralase Partners with University of Ulm
November 11, 2015
Tags
Business & Professional Services
From
ACCESSWIRE
Theralase Anti-Cancer Technology Presented at International Laser Conference
November 09, 2015
Tags
Business & Professional Services
Conferences
From
ACCESSWIRE
Theralase Anti-Cancer Technology Research Published in International Journal
October 27, 2015
Tags
Business & Professional Services
Company Update
From
ACCESSWIRE
Theralase Releases AGM Presentation Videos
October 08, 2015
Tags
Business & Professional Services
Company Update
From
ACCESSWIRE
Theralase Completes GMP Manufacture of Second Batch of Lead Drug
October 01, 2015
Tags
Business & Professional Services
Company Update
From
ACCESSWIRE
Theralase Submits Anti-Cancer Technology to Research Ethics Board for Approval
September 21, 2015
Tags
Company Update
Business & Professional Services
From
ACCESSWIRE
Theralase Submits Investigational Testing Authorization to Health Canada for Approval
September 18, 2015
Tags
Company Update
Publishing & Media
From
ACCESSWIRE
Theralase Submits Clinical Trial Application to Health Canada for Approval
September 17, 2015
Tags
Company Update
Business & Professional Services
From
ACCESSWIRE
Theralase Completes Detailed Information on the TLC-3000B Laser System
September 15, 2015
Tags
Company Update
Business & Professional Services
From
ACCESSWIRE
Theralase Completes Clinical Protocol
September 11, 2015
Tags
Business & Professional Services
Product Announcements
From
ACCESSWIRE
Theralase Successfully Completes GLP Toxicology Analysis of Lead Drug
September 10, 2015
Tags
Business & Professional Services
Product Announcements
From
ACCESSWIRE
Theralase Research Demonstrates Lead Drug Also Effective for Muscle Invasive Bladder Cancer
September 09, 2015
Tags
Business & Professional Services
From
ACCESSWIRE
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.